353 related articles for article (PubMed ID: 31804606)
1. Ganoderic acid hinders renal fibrosis via suppressing the TGF-β/Smad and MAPK signaling pathways.
Geng XQ; Ma A; He JZ; Wang L; Jia YL; Shao GY; Li M; Zhou H; Lin SQ; Ran JH; Yang BX
Acta Pharmacol Sin; 2020 May; 41(5):670-677. PubMed ID: 31804606
[TBL] [Abstract][Full Text] [Related]
2. The glucagon-like peptide-1 (GLP-1) analog liraglutide attenuates renal fibrosis.
Li YK; Ma DX; Wang ZM; Hu XF; Li SL; Tian HZ; Wang MJ; Shu YW; Yang J
Pharmacol Res; 2018 May; 131():102-111. PubMed ID: 29530599
[TBL] [Abstract][Full Text] [Related]
3. Nootkatone confers antifibrotic effect by regulating the TGF-β/Smad signaling pathway in mouse model of unilateral ureteral obstruction.
Gairola S; Ram C; Syed AM; Doye P; Kulhari U; Mugale MN; Murty US; Sahu BD
Eur J Pharmacol; 2021 Nov; 910():174479. PubMed ID: 34480883
[TBL] [Abstract][Full Text] [Related]
4. Apamin inhibits renal fibrosis via suppressing TGF-β1 and STAT3 signaling in vivo and in vitro.
Gwon MG; An HJ; Gu H; Kim YA; Han SM; Park KK
J Mol Med (Berl); 2021 Sep; 99(9):1265-1277. PubMed ID: 34031696
[TBL] [Abstract][Full Text] [Related]
5. HuangQi Decoction Ameliorates Renal Fibrosis via TGF-β/Smad Signaling Pathway In Vivo and In Vitro.
Zhao J; Wang L; Cao AL; Jiang MQ; Chen X; Wang Y; Wang YM; Wang H; Zhang XM; Peng W
Cell Physiol Biochem; 2016; 38(5):1761-74. PubMed ID: 27161221
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus-mediated P311 ameliorates renal fibrosis through inhibition of epithelial-mesenchymal transition via TGF-β1-Smad-ILK pathway in unilateral ureteral obstruction rats.
Qi FH; Cai PP; Liu X; Si GM
Int J Mol Med; 2018 May; 41(5):3015-3023. PubMed ID: 29436600
[TBL] [Abstract][Full Text] [Related]
7. Alpha1-Antitrypsin Attenuates Renal Fibrosis by Inhibiting TGF-β1-Induced Epithelial Mesenchymal Transition.
Cho JH; Ryu HM; Oh EJ; Yook JM; Ahn JS; Jung HY; Choi JY; Park SH; Kim YL; Kwak IS; Kim CD
PLoS One; 2016; 11(9):e0162186. PubMed ID: 27607429
[TBL] [Abstract][Full Text] [Related]
8. Tamoxifen ameliorates renal tubulointerstitial fibrosis by modulation of estrogen receptor α-mediated transforming growth factor-β1/Smad signaling pathway.
Kim D; Lee AS; Jung YJ; Yang KH; Lee S; Park SK; Kim W; Kang KP
Nephrol Dial Transplant; 2014 Nov; 29(11):2043-53. PubMed ID: 25031017
[TBL] [Abstract][Full Text] [Related]
9. Pirfenidone suppresses MAPK signalling pathway to reverse epithelial-mesenchymal transition and renal fibrosis.
Li Z; Liu X; Wang B; Nie Y; Wen J; Wang Q; Gu C
Nephrology (Carlton); 2017 Aug; 22(8):589-597. PubMed ID: 27245114
[TBL] [Abstract][Full Text] [Related]
10. MFAP4 deficiency alleviates renal fibrosis through inhibition of NF-κB and TGF-β/Smad signaling pathways.
Pan Z; Yang K; Wang H; Xiao Y; Zhang M; Yu X; Xu T; Bai T; Zhu H
FASEB J; 2020 Nov; 34(11):14250-14263. PubMed ID: 32905637
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-302b mitigates renal fibrosis via inhibiting TGF-β/Smad pathway activation.
Sun M; Zhou W; Yao F; Song J; Xu Y; Deng Z; Diao H; Li S
Braz J Med Biol Res; 2021; 54(3):e9206. PubMed ID: 33503202
[TBL] [Abstract][Full Text] [Related]
12. Chrysophanol ameliorates renal interstitial fibrosis by inhibiting the TGF-β/Smad signaling pathway.
Dou F; Ding Y; Wang C; Duan J; Wang W; Xu H; Zhao X; Wang J; Wen A
Biochem Pharmacol; 2020 Oct; 180():114079. PubMed ID: 32511988
[TBL] [Abstract][Full Text] [Related]
13. Astragaloside IV inhibits renal tubulointerstitial fibrosis by blocking TGF-β/Smad signaling pathway in vivo and in vitro.
Wang L; Chi YF; Yuan ZT; Zhou WC; Yin PH; Zhang XM; Peng W; Cai H
Exp Biol Med (Maywood); 2014 Oct; 239(10):1310-24. PubMed ID: 24879422
[TBL] [Abstract][Full Text] [Related]
14. Microparticles derived from human erythropoietin mRNA-transfected mesenchymal stem cells inhibit epithelial-to-mesenchymal transition and ameliorate renal interstitial fibrosis.
Lee M; Kim SH; Jhee JH; Kim TY; Choi HY; Kim HJ; Park HC
Stem Cell Res Ther; 2020 Sep; 11(1):422. PubMed ID: 32993806
[TBL] [Abstract][Full Text] [Related]
15. Specific Inhibitor of Smad3 (SIS3) Attenuates Fibrosis, Apoptosis, and Inflammation in Unilateral Ureteral Obstruction Kidneys by Inhibition of Transforming Growth Factor β (TGF-β)/Smad3 Signaling.
Ji X; Wang H; Wu Z; Zhong X; Zhu M; Zhang Y; Tan R; Liu Y; Li J; Wang L
Med Sci Monit; 2018 Mar; 24():1633-1641. PubMed ID: 29555895
[TBL] [Abstract][Full Text] [Related]
16. TGF-β1 receptor blockade attenuates unilateral ureteral obstruction-induced renal fibrosis in C57BL/6 mice through attenuating Smad and MAPK pathways.
Nazari Soltan Ahmad S; Kalantary-Charvadeh A; Hamzavi M; Ezzatifar F; Aboutalebi Vand Beilankouhi E; Toofani-Milani A; Geravand F; Golshadi Z; Mesgari-Abbasi M
J Mol Histol; 2022 Aug; 53(4):691-698. PubMed ID: 35704228
[TBL] [Abstract][Full Text] [Related]
17. Lefty-1 inhibits renal epithelial-mesenchymal transition by antagonizing the TGF-β/Smad signaling pathway.
Zhang L; Liu X; Liang J; Wu J; Tan D; Hu W
J Mol Histol; 2020 Feb; 51(1):77-87. PubMed ID: 32065356
[TBL] [Abstract][Full Text] [Related]
18. Thymosin β4 alleviates renal fibrosis and tubular cell apoptosis through TGF-β pathway inhibition in UUO rat models.
Yuan J; Shen Y; Yang X; Xie Y; Lin X; Zeng W; Zhao Y; Tian M; Zha Y
BMC Nephrol; 2017 Oct; 18(1):314. PubMed ID: 29047363
[TBL] [Abstract][Full Text] [Related]
19. Low-dose paclitaxel ameliorates renal fibrosis by suppressing transforming growth factor-β1-induced plasminogen activator inhibitor-1 signaling.
Jung ES; Lee J; Heo NJ; Kim S; Kim DK; Joo KW; Han JS
Nephrology (Carlton); 2016 Jul; 21(7):574-82. PubMed ID: 26869361
[TBL] [Abstract][Full Text] [Related]
20. Rosmarinic acid ameliorates renal interstitial fibrosis by inhibiting the phosphorylated-AKT mediated epithelial-mesenchymal transition
Hsieh YH; Tsai JP; Ting YH; Hung TW; Chao WW
Food Funct; 2022 Apr; 13(8):4641-4652. PubMed ID: 35373225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
